Health economics and effectiveness analysis of generic anti-diabetic medication from jan aushadhi: An ambispective study in community pharmacy

• Published in: Diabetes & metabolic syndrome clinical research & reviews Vol. 15; no. 6; p. 102303
• Main Authors: Chaudhary, Raushan Kumar, Philip, Melwin Johns, Santhosh, Ashly, Karoli, Satish S., Bhandari, Ramesh, Ganachari, M.S.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.11.2021
• Subjects: Biomarkers - blood; Blood Glucose - analysis; Cost variation analysis; Cost-Benefit Analysis; Cost-effectiveness analysis; Diabetes mellitus; Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - economics; Drug Therapy, Combination; Drugs, Generic - economics; Drugs, Generic - therapeutic use; Female; Follow-Up Studies; Glycated Hemoglobin A - analysis; HbA1c; Humans; Hypoglycemic Agents - classification; Hypoglycemic Agents - economics; Hypoglycemic Agents - therapeutic use; ICER; India; Male; Middle Aged; Pharmacies - statistics & numerical data; Prognosis; Socioeconomic status; India; OOPE; SES; Cost-effectiveness analysis; Socioeconomic status; Cost variation analysis; ICER; Diabetes mellitus; QALY; DPP4I; MACCE; HbA1c; CEA

The pharmacotherapy of diabetes mellitus has a colossal economic burden, which demands cost-effective therapy, as the patients have to be on treatment lifelong. Thus, our study aimed to study cost variation and effectiveness analysis among type 2 diabetic patients. We conducted ambi-spective researc...